Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Predicting realistic RBE values for clinically relevant radiotherapy schedules

J Denekamp1, T Waites, J F Fowler

  • 1Oncology Department, University of Umeå, Sweden.

International Journal of Radiation Biology
|June 1, 1997
PubMed
Summary

Radiation effect modifiers require careful consideration of dose and tissue type for clinical application. Their effectiveness varies with dose per fraction and cellular characteristics, necessitating translation from preclinical studies to patient treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is sensitization with nicotinamide and carbogen dependent on nicotinamide concentration at the time of irradiation?

International journal of radiation biology·2004
Same author

High-dose-rate brachytherapy at 14 Gy per hour to point A: preliminary results of a prospectively designed schedule for cancer of the cervix based on the linear-quadratic model.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2002
Same author

The Denekamp diadems--a review of Julie's achievements.

Acta oncologica (Stockholm, Sweden)·2002
Same author

Theoretical simulation of oxygen tension measurement in tissues using a microelectrode: I. The response function of the electrode.

Physiological measurement·2002
Same author

Biological factors influencing optimum fractionation in radiation therapy.

Acta oncologica (Stockholm, Sweden)·2002
Same author

A skin moisturizing cream containing Quaternium-18-Bentonite effectively improves chronic hand dermatitis.

Journal of cutaneous medicine and surgery·2001

Area of Science:

  • Radiation oncology
  • Radiobiology
  • Medical physics

Background:

  • Therapeutic potential of radiation effect modifiers is crucial for cancer treatment.
  • Preclinical findings on radiation modifiers must be relevant to clinical radiation doses.
  • Clinical radiation schedules involve fractionated doses, differing from initial high-dose studies.

Purpose of the Study:

  • To analyze the dose and tissue-specific effects of radiation effect modifiers.
  • To evaluate the relevance of preclinical data for clinical application of radiation modifiers.
  • To understand how cellular characteristics influence modifier efficacy in fractionated radiotherapy.

Main Methods:

  • Utilized the linear-quadratic (LQ) model to dissect dose-dependent effects of radiation modifiers.

Related Experiment Videos

  • Considered variations in alpha/beta ratios across different tissue types.
  • Analyzed the impact of cellular heterogeneity and cell cycle redistribution during fractionated treatment.

    • Main Results:

    • Radiation modifiers exhibit dose and dose per fraction dependence, not acting uniformly across all doses.
    • Modifier efficacy differs based on tissue-specific alpha/beta ratios and cellular composition.
    • Cellular dynamics, including re-assortment, significantly influence the overall response to fractionated radiation schedules.

    Conclusions:

    • Translating preclinical findings on radiation modifiers to clinical practice requires careful consideration of dose, fractionation, and tissue-specific factors.
    • The LQ model provides a framework for understanding and predicting the complex behavior of radiation modifiers.
    • Accurate prediction of clinical benefit necessitates accounting for dose-dependent effects and cellular responses within tumors and normal tissues.